Merck's Ebola vaccine proves fully effective in Guinea trial

LONDON, July 31 (Reuters) - An Ebola vaccine developed in record time has proved highly effective against the deadly virus in a large trial in Guinea and could now be used to help end a vast outbreak in West Africa, researchers said on Friday.